Allspring Global Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16
Closed -$107 2547
2024
Q1
$107 Sell
16
-67
-81% -$461 ﹤0.01% 2290
2023
Q4
$539 Sell
83
-2,874
-97% -$18.5K ﹤0.01% 2156
2023
Q3
$27.9K Sell
2,957
-61,578
-95% -$741K ﹤0.01% 2438
2023
Q2
$902K Buy
64,535
+55,750
+635% +$950K ﹤0.01% 1443
2023
Q1
$165K Buy
8,785
+1,169
+15% +$19.2K ﹤0.01% 1876
2022
Q4
$105K Sell
7,616
-167
-2% -$2.56K ﹤0.01% 2061
2022
Q3
$148K Buy
7,783
+4,741
+156% +$86.4K ﹤0.01% 1920
2022
Q2
$46K Sell
3,042
-75,604
-96% -$1.12M ﹤0.01% 2285
2022
Q1
$1.6M Sell
78,646
-83,763
-52% -$1.71M ﹤0.01% 1619
2021
Q4
$4.74M Buy
+162,409
New +$4.65M 0.01% 1192

Other funds holding CDMO

Allspring Global Investments's CDMO Position: Q2 2024 in Review

Allspring Global Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2024, closing a stake of 16 shares — an estimated $107 sold.

Allspring Global Investments first reported a position in CDMO in Q4 2021 and held it in 10 quarters. The position peaked at $4.74M in Q4 2021. 172 funds tracked by Wall St. Rank hold CDMO as of Q2 2024.

  • Allspring Global Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 16 Avid Bioservices, Inc. Common Stock shares in Q2 2024, an estimated $107.
  • Allspring Global Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Allspring Global Investments's Avid Bioservices, Inc. Common Stock position peaked at $4.74M in Q4 2021.
  • 172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.